Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
3.540
-0.170 (-4.58%)
At close: Jan 16, 2026, 4:00 PM EST
3.478
-0.062 (-1.75%)
After-hours: Jan 16, 2026, 7:49 PM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $8.02 million as of January 16, 2026. Its market cap has increased by 167.36% in one year.
Market Cap
8.02M
Enterprise Value
1.71M
1-Year Change
167.36%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $8.02M, a decrease of -76.68%. That is a compound annual growth rate of -24.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 8.40M | 29.23% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.45B |
| Johnson & Johnson | 528.07B |
| AbbVie | 382.83B |
| UnitedHealth Group | 306.05B |
| AstraZeneca | 291.28B |
| Novartis AG | 278.73B |
| Merck & Co. | 276.45B |
| Novo Nordisk | 252.12B |